Core Concepts
Vagal nerve stimulation combined with intense physical rehabilitation in chronic stroke patients leads to significant improvements in hand and arm function lasting up to 1 year.
Abstract
The study conducted by Teresa J. Kimberley, PhD, focused on the benefits of vagal nerve stimulation in chronic stroke patients. The VNS-REHAB pivotal trial enrolled 108 patients with moderate to severe impairment of arm or hand function. The study showed that improvements in hand and arm function were maintained for up to 1 year, with significant improvements in motor function assessed through the Fugl-Meyer Assessment-Upper Extremity (FMA-UE) and the Wolf Motor Function Test (WMFT). The study demonstrated that the benefits of vagal nerve stimulation combined with physical rehabilitation were consistent across different domains of function, including impairment, activity, and quality of life. The positive results were maintained even during the COVID-19 pandemic, showcasing the robustness of the findings.
Key Highlights:
- Vagal nerve stimulation combined with physical rehabilitation improves hand and arm function in chronic stroke patients.
- Benefits of the intervention were maintained for up to 1 year.
- Significant improvements were observed in motor function assessments.
- The study showed consistency in improvements across different domains of function.
- The positive results were maintained even during the COVID-19 pandemic.
Stats
The FMA-UE score improved by 5.3 points, and WMFT score improved by 0.51 points.
Roughly 50% of all people experienced clinically meaningful improvements in both the FMA and WMFT scores.
Quotes
"An extraordinary ray of hope for people with chronic stroke." - Teresa J. Kimberley, PhD
"People got better in the impairment measure, the activity measurement, and the quality-of-life measures, which suggests that these findings really are robust." - Teresa J. Kimberley, PhD
"We have had a lot of candidates, a lot of forms of potentially stimulating the brain to encourage it or help it recover, but this is the first treatment that really has met the bar to become an FDA-approved treatment to facilitate recovery after stroke." - Joel Stein, MD